Seasonal Adherence To, and Effectiveness Of, Subcutaneous Interferon Β-1a Administered by RebiSmart® in Patients With Relapsing Multiple Sclerosis: Results of the 1-Year, Observational GEPAT-SMART Study
BMC Neurology - United Kingdom
doi 10.1186/s12883-018-1179-0
Full Text
Open PDFAbstract
Available in full text
Date
November 6, 2018
Authors
Publisher
Springer Science and Business Media LLC